Introduction: The study aimed to explore the psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI VFQ) and Impact of Vision Impairment (IVI) profile in recessive Stargardt disease (STGD1). Methods: The NEI VFQ-25 and IVI-28 were administered to individuals with STGD1. Responses were analyzed following psychometrically established dimension structures of the NEI VFQ (visual function [VF] subscale; socioemotional [SE] subscale) and of the IVI (functional [F] subscale; emotional [E] subscale). We analyzed internal consistency, dimensionality, item fit, and differential item functioning (DIF), using latent trait models. Criterion validity was assessed using Pearson correlation coefficients. Results: Seventy-one participants (42 females, 29 males; mean age, 44 ± 19 years) were included. Self-reported difficulty levels were lower than the mean difficulty of items in both instruments. Person reliability and person separation index of the instruments were 0.85 and 2.40 (NEI VFQ-VF), 0.69 and 1.49 (NEI-VFQ-SE), 0.88 and 2.77 (IVI-F), and 0.72 and 1.62 (IVI-E). No items showed misfit at a level distorting the measurement system. One IVI item showed DIF by gender but was retained as person measures were largely unaffected by its removal. NEI VFQ-VF and IVI-F as well as NEI VFQ-SE and IVI-E were positively correlated (r = 0.79 and 0.64, respectively). Conclusion: The NEI VFQ and IVI have acceptable psychometric properties in STGD1 with the IVI allowing more sensitive person stratification. Targeting of questionnaires to individuals with STGD1 might be improved by including additional content domains specific to the disease.

1.
Hanany
M
,
Rivolta
C
,
Sharon
D
.
Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases
.
Proc Natl Acad Sci U S A
.
2020
;
117
(
5
):
2710
6
.
2.
Blacharski
PA
.
Fundus flavimaculatus
. In:
Newsome
DA
, editors.
Retinal dystrophies and degenerations
.
New York
:
Raven Press
;
1988
.
3.
Müller
PL
,
Fimmers
R
,
Gliem
M
,
Holz
FG
,
Charbel Issa
P
.
Choroidal alterations in ABCA4-related retinopathy
.
Retina
.
2017
;
37
(
2
):
359
67
.
4.
Müller
PL
,
Pfau
M
,
Möller
PT
,
Nadal
J
,
Schmid
M
,
Lindner
M
,
.
Choroidal flow signal in late-onset Stargardt disease and age-related macular degeneration: an OCT-angiography study
.
Invest Ophthalmol Vis Sci
.
2018
;
59
(
4
):
AMD122
31
.
5.
Müller
PL
,
Pfau
M
,
Treis
T
,
Pascual-Camps
I
,
Birtel
J
,
Lindner
M
,
.
Progression of ABCA4-related retinopathy: prognostic value of demographic, functional, genetic, and imaging parameters
.
Retina
.
2020
;
40
(
12
):
2343
56
.
6.
Alabduljalil
T
,
Patel
RC
,
Alqahtani
AA
,
Gao
SS
,
Gale
MJ
,
Zhang
M
,
.
Correlation of outer retinal degeneration and choriocapillaris loss in Stargardt disease using en face optical coherence tomography and optical coherence tomography angiography
.
Am J Ophthalmol
.
2019
;
202
:
79
90
.
7.
Cremers
FPM
,
Lee
W
,
Collin
RWJ
,
Allikmets
R
.
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations
.
Prog Retin Eye Res
.
2020
;
79
:
100861
.
8.
Hussain
RM
,
Ciulla
TA
,
Berrocal
AM
,
Gregori
NZ
,
Flynn
HW
,
Lam
BL
.
Stargardt macular dystrophy and evolving therapies
.
Expert Opin Biol Ther
.
2018
;
18
(
10
):
1049
59
.
9.
D’Amanda
CS
,
Nolen
R
,
Huryn
LA
,
Turriff
A
.
Psychosocial impacts of Mendelian eye conditions: a systematic literature review
.
Surv Ophthalmol
.
2020
;
65
(
5
):
562
80
.
10.
Csaky
K
,
Ferris
F
,
Chew
EY
,
Nair
P
,
Cheetham
JK
,
Duncan
JL
.
Report from the NEI/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases
.
Invest Ophthalmol Vis Sci
.
2017
;
58
(
9
):
3456
63
.
11.
Müller
PL
,
Odainic
A
,
Treis
T
,
Herrmann
P
,
Tufail
A
,
Holz
FG
,
.
Inferred retinal sensitivity in recessive Stargardt disease using machine learning
.
Sci Rep
.
2021
;
11
(
1
):
1466
.
12.
Müller
PL
,
Treis
T
,
Odainic
A
,
Pfau
M
,
Herrmann
P
,
Tufail
A
,
.
Prediction of function in ABCA4-related retinopathy using ensemble machine learning
.
J Clin Med
.
2020
;
9
(
8
):
2428
.
13.
Mangione
CM
,
Lee
PP
,
Pitts
J
,
Gutierrez
P
,
Berry
S
,
Hays
RD
.
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators
.
Arch Ophthalmol
.
1998
;
116
(
11
):
1496
504
.
14.
Mangione
CM
,
Lee
PP
,
Gutierrez
PR
,
Spritzer
K
,
Berry
S
,
Hays
RD
,
.
Development of the 25-item National Eye Institute Visual Function Questionnaire
.
Arch Ophthalmol
.
2001
;
119
(
7
):
1050
8
.
15.
Braithwaite
T
,
Calvert
M
,
Gray
A
,
Pesudovs
K
,
Denniston
AK
.
The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice
.
Patient Relat Outcome Meas
.
2019
;
10
:
9
24
.
16.
Pesudovs
K
,
Gothwal
VK
,
Wright
T
,
Lamoureux
EL
.
Remediating serious flaws in the National Eye Institute Visual Function Questionnaire
.
J Cataract Refract Surg
.
2010
;
36
(
5
):
718
32
.
17.
Marella
M
,
Pesudovs
K
,
Keeffe
JE
,
O’Connor
PM
,
Rees
G
,
Lamoureux
EL
.
The psychometric validity of the NEI VFQ-25 for use in a low-vision population
.
Invest Ophthalmol Vis Sci
.
2010
;
51
(
6
):
2878
84
.
18.
Dougherty
BE
,
Bullimore
MA
.
Comparison of scoring approaches for the NEI VFQ-25 in low vision
.
Optom Vis Sci
.
2010
;
87
(
8
):
543
8
.
19.
Mollazadegan
K
,
Huang
J
,
Khadka
J
,
Wang
Q
,
Yang
F
,
Gao
R
,
.
Cross-cultural validation of the National Eye Institute Visual Function Questionnaire
.
J Cataract Refract Surg
.
2014
;
40
(
5
):
774
84
.
20.
Franke
GH
,
Esser
J
,
Voigtländer
A
,
Mähner
N
.
Der National Eye Institute Visual Function Questionnaire (NEI-VFQ): Erste Ergebnisse zur psychometrischen Überprüfung eines Verfahrens zur Erfassung der Lebensqualität bei Sehbeeinträchtigten
.
Z Med Psychol
.
1998
;
7
(
4
):
178
84
.
21.
Nickels
S
,
Schuster
AK
,
Singer
S
,
Wild
PS
,
Laubert-Reh
D
,
Schulz
A
,
.
The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25): reference data from the German population-based Gutenberg Health Study (GHS)
.
Health Qual Life Outcomes
.
2017
;
15
(
1
):
156
.
22.
Weih
LM
,
Hassell
JB
,
Keeffe
J
.
Assessment of the impact of vision impairment
.
Invest Ophthalmol Vis Sci
.
2002
;
43
(
4
):
927
35
.
23.
Lamoureux
EL
,
Pallant
JF
,
Pesudovs
K
,
Hassell
JB
,
Keeffe
JE
.
The impact of vision impairment questionnaire: an evaluation of its measurement properties using rasch analysis
.
Invest Ophthalmol Vis Sci
.
2006
;
47
(
11
):
4732
41
.
24.
Lamoureux
EL
,
Pallant
JF
,
Pesudovs
K
,
Rees
G
,
Hassell
JB
,
Keeffe
JE
.
The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis
.
Invest Ophthalmol Vis Sci
.
2007
;
48
(
3
):
1001
6
.
25.
Finger
RP
,
Fenwick
E
,
Marella
M
,
Dirani
M
,
Holz
FG
,
Chiang
PP-C
,
.
The impact of vision impairment on vision-specific quality of life in Germany
.
Invest Ophthalmol Vis Sci
.
2011
;
52
(
6
):
3613
9
.
26.
Rasch
G
.
Studies in mathematical psychology: I. Probabilistic models for some intelligence and attainment tests
.
Copenhagen
:
Danmarks Paedagogiske Institut
;
1960
.
27.
Wright
BD
,
Linacre
JM
.
Reasonable mean-square fit values
.
Rasch Meas Trans
.
1994
;
8
:
370
.
28.
Bond
TG
,
Fox
CM
.
Applying the Rasch model: fundamental measurement in the human sciences
.
Mahwah, NJ
:
Lawrence Erlbaum Associates Publishers
;
2001
.
29.
Boone
WJ
,
Noltemeyer
A
,
Yates
G
.
Rasch analysis: a primer for school psychology researchers and practitioners
.
Cogent Education
.
2017
;
4
(
1
):
1416898
.
30.
Khadka
J
,
McAlinden
C
,
Pesudovs
K
.
Quality assessment of ophthalmic questionnaires: review and recommendations
.
Optom Vis Sci
.
2013
;
90
(
8
):
720
44
.
31.
Linacre
JM
.
WINSTEPS Rasch measurement computer program
.
Chicago
:
Winsteps.com
;
2016
.
32.
Müller
PL
,
Treis
T
,
Pfau
M
,
Esposti
SD
,
Alsaedi
A
,
Maloca
P
,
.
Progression of retinopathy secondary to maternally inherited diabetes and deafness: evaluation of predicting parameters
.
Am J Ophthalmol
.
2020
;
213
:
134
44
.
33.
Lois
N
,
Holder
GE
,
Bunce
C
,
Fitzke
FW
,
Bird
AC
.
Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus
.
Arch Ophthalmol
.
2001
;
119
(
3
):
359
69
.
34.
Varma
R
,
Richman
EA
,
Ferris
FL
,
Bressler
NM
.
Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA clinical trial endpoints symposium
.
Invest Ophthalmol Vis Sci
.
2010
;
51
(
12
):
6095
103
.
35.
Csaky
KG
,
Richman
EA
,
Ferris
FL
.
Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium
.
Invest Ophthalmol Vis Sci
.
2008
;
49
(
2
):
479
89
.
36.
Fishman
GA
,
Farber
M
,
Patel
BS
,
Derlacki
DJ
.
Visual acuity loss in patients with Stargardt’s macular dystrophy
.
Ophthalmology
.
1987
;
94
(
7
):
809
14
.
37.
Lacy
GD
,
Abalem
MF
,
Musch
DC
,
Jayasundera
KT
.
Patient-reported outcome measures in inherited retinal degeneration gene therapy trials
.
Ophthalmic Genet
.
2020
;
41
(
1
):
1
6
.
38.
Lacy
GD
,
Abalem
MF
,
Andrews
CA
,
Popova
LT
,
Santos
EP
,
Yu
G
,
.
The Michigan retinal degeneration questionnaire: a patient-reported outcome instrument for inherited retinal degenerations
.
Am J Ophthalmol
.
2021
;
222
:
60
8
.
39.
Murro
V
,
Sodi
A
,
Giacomelli
G
,
Mucciolo
DP
,
Pennino
M
,
Virgili
G
,
.
Reading ability and quality of life in Stargardt disease
.
Eur J Ophthalmol
.
2017
;
27
(
6
):
740
5
.
40.
Sung
Y
,
Lee
MJ
,
Choi
J
,
Jung
SY
,
Chong
SY
,
Sung
JH
,
.
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients
.
Br J Ophthalmol
.
2021
;
105
(
6
):
829
37
.
41.
Kubota
R
,
Birch
DG
,
Gregory
JK
,
Koester
JM
.
Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease
.
Br J Ophthalmol
.
2022
;
106
(
3
):
403
8
.
42.
Roborel de Climens
A
,
Tugaut
B
,
Dias Barbosa
C
,
Buggage
R
,
Brun-Strang
C
.
Living with Stargardt disease: insights from patients and their parents
.
Ophthalmic Genet
.
2021
;
42
(
2
):
150
60
.
43.
Gomes
MLS
,
Corrêa
H
,
Duarte
D
,
Rückl
S
,
Brancaglion
MYM
,
Frasson
M
.
Depression and quality of life in individuals with Stargardt’s disease
.
J Bras Psiquiatr
.
2020
;
69
(
1
):
44
7
.
44.
Las Hayas
C
,
Bilbao
A
,
Quintana
JM
,
Garcia
S
,
Lafuente
I
;
IRYSS Cataract Group
.
A comparison of standard scoring versus rasch scoring of the visual function index-14 in patients with cataracts
.
Invest Ophthalmol Vis Sci
.
2011
;
52
(
7
):
4800
7
.
You do not currently have access to this content.